What Is Alpha-Gal Syndrome?

An Essay on Anaphylaxis to Bovine Proteins, the Tick Story That Followed, and the Proposal to Deploy It

The Nobel Prize for Meat Anaphylaxis, 1913

The mechanism behind alpha-gal syndrome won the Nobel Prize in 1913. The lone star tick was not credited with producing meat allergy in humans until 2009.

The work that follows builds on the reporting of Sasha Latypova at Due Diligence and Art. Her two pieces on alpha-gal, and on what she has called the “weaponized ticks” mythology more broadly, connected the syndrome to vaccine injury, identified the ICD coding timeline that absorbed the post-mRNA cases, and surfaced the Liao proposal as the deliberate-deployment shadow behind the cover story. This essay deepens the historical and mechanistic case she opened.

Charles Richet sensitized dogs to raw meat by injecting bovine proteins into their bloodstream, then documented the catastrophic systemic collapse that followed.¹ He named the response by pairing the Greek ana (against) with phylaxis (protection), marking it as the failed inverse of what vaccinators had been promising.² He had been refining the experimental program since 1902.

The procedure was deliberate. The dogs were fed cooked meat first, with their white blood cell levels measured as normal. When they were fed raw meat, those levels rose, which Richet attributed to the digestive system mounting a defense against proteins it had not finished modifying. He then bypassed digestion entirely by injecting the raw meat proteins directly into the circulation. The dogs developed anaphylaxis: violent, systemic, sometimes fatal.

The work is not obscure. Richet’s 1913 Nobel lecture lays out the mechanism, and standard immunology textbooks have reproduced it ever since. He demonstrated the phenomenon in dogs, cats, rabbits, horses, and frogs, and described its universality across species in his acceptance speech.³ He named the mechanism precisely. Anaphylaxis is the body’s response to proteins that have bypassed the modifying action of the digestive tract and been introduced directly to the circulation. The first injection sensitizes. After an incubation period of weeks, a second exposure (by injection, or by ingestion) triggers the violent response.⁴

Dogs eat raw meat all the time without developing anaphylaxis. Richet was clear about this at the 1913 International Medical Congress in London. “Experimental alimentary anaphylaxis is difficult to bring about under conditions of healthy digestion, since it is a question of toxalbumins or nutritive albumins ... because the digestive juices actively intervene in transforming these albumins and rendering them innocuous.”⁵ The condition is created by combining injection with subsequent exposure. Injection is the maker.

A hundred and seven years before the lone star tick was credited with producing meat allergy in humans, the Nobel committee gave its highest medical honor to a Frenchman who had created meat allergy in dogs by injecting bovine proteins into them. The mechanism was published in the peer-reviewed literature of every Western country and recognized at the highest institutional level. The condition now called alpha-gal syndrome is the same mechanism, in the same direction, against the same proteins. Only the cover story has changed.

This work stays free because paid subscribers make it possible. They get the full book library, the Deep Dive Audio Library, and the Questions for Your Doctor, Before You Consent, and Package Insert series. No grants, no gatekeepers — your subscription is what keeps it that way.

---

The Cetuximab Discovery, 2008

In the early 2000s, the chimeric mouse-human protein cetuximab (trade name Erbitux) was introduced for colorectal cancer and squamous cell carcinoma of the head and neck. Cetuximab is manufactured in a mouse cell line called SP2/0. Because mouse cells make the sugar molecule galactose-alpha-1,3-galactose (alpha-gal) and human cells do not, cetuximab carries alpha-gal residues on its surface.⁶ Humans, apes, and Old World monkeys lack the enzyme that makes alpha-gal. The human circulation treats it as foreign.

Oncologists in the southeastern United States noticed something strange. In Tennessee and North Carolina, 22% of cetuximab patients suffered immediate hypersensitivity reactions on their first infusion. In the northeastern US, the figure was under 1%.⁷ The regional pattern was striking. Patients were reacting violently to a drug they had never been exposed to before, which meant something had sensitized them in advance.

Christine Chung and Thomas Platts-Mills’ team at Vanderbilt and the University of Virginia investigated. Of 76 cetuximab-treated patients, 25 had hypersensitivity reactions. Of those 25, 17 carried pre-existing IgE antibodies to cetuximab in their serum before receiving the drug. The target was identified at the molecular level. It was not a protein but the alpha-gal sugar itself.⁸

The Chung paper, published in the New England Journal of Medicine in March 2008, established the mechanism (injection of an alpha-gal-bearing biologic produced anaphylaxis), identified the target at the molecular level (the alpha-gal sugar), and demonstrated that the patients had been sensitized by something else before they ever encountered the drug. This is the establishment’s own modern rediscovery of Richet, conducted in a teaching hospital, peer-reviewed in the most prestigious medical journal in the United States, with full molecular characterization of the target. None of this required ticks. The Chung paper barely mentioned them.

Cetuximab is not the only modern biologic to produce this pattern. Other monoclonal antibodies manufactured in mammalian cell lines, equine-derived antivenoms, and gelatin-containing biologic preparations have all generated anti-alpha-gal reactivity in patients who received them. The mechanism is consistent across the class. Inject mammalian-derived material; sensitization follows; subsequent exposure produces anaphylaxis. Cetuximab is the case where regional clustering forced the discovery into the open, but the pattern was visible across the modern biologics field before the tick narrative absorbed it.

The question the establishment then faced was direct. If cetuximab patients in Tennessee already carried anti-alpha-gal antibodies before treatment, what had sensitized them? The answer that mainstream allergy literature eventually settled on was the lone star tick. Within two years of the Chung paper, Scott Commins and Platts-Mills published a follow-up describing delayed anaphylaxis after red meat consumption in patients with the same specificity, and proposed tick bites as the originating exposure.⁹ The tick narrative had to be constructed because the establishment could not look at the alternative explanation. The alternative was that the southeastern US patients had received decades of injections containing mammalian proteins (gelatin, bovine serum albumin, mouse cell line residues) in vaccines and biologics, and had been sensitized by what Richet had explicitly described.

---

The Idiopathic Gap

There is a second piece of arithmetic that explains why the tick story took hold so quickly. In a 2013 nationwide US anaphylaxis survey conducted by Wood and colleagues, a substantial fraction of reported cases were classified as idiopathic. Cause unknown.¹⁰ The broader idiopathic anaphylaxis literature places this figure between 30% and 60% of adult cases.¹¹ Two of every five severe anaphylactic episodes, give or take, were happening with no identifiable trigger, in a country where allergy specialists are well-resourced and well-trained. The standard allergen avoidance strategies, which depend on identifying the trigger, were failing for nearly half of severe cases.

When alpha-gal emerged as a category, mainstream allergists welcomed it as a way to reclassify cases that “would previously have been classified as idiopathic.”¹² A diagnostic gap of that size creates pressure for almost any plausible label. A tick-borne carbohydrate allergy with a delayed-onset symptom pattern was perfectly shaped to absorb cases the system could not otherwise explain. The pattern (eat dinner, react three to six hours later, no obvious culprit) could now be assigned to a tick bite that may have occurred weeks or months before.

What the idiopathic figure obscures is the more important question. If 30% to 60% of anaphylactic cases are idiopathic in a country where the average child receives more than 70 doses of vaccine ingredients by age 18, and where the schedule includes injected mammalian proteins (gelatin, bovine serum albumin) of the kind Richet’s mechanism implicates, with aluminum adjuvant amplifying the response per Vasselev’s 1978 finding, the obvious hypothesis is not a tick. The obvious hypothesis is the injection schedule. The tick fills the idiopathic gap precisely because the alternative explanation is structurally unavailable to the field that creates the codes and writes the studies.

---

What Is Actually Being Injected

Gelatin appears as a stabilizer in at least eleven US vaccines, including MMR, MMRV, varicella, shingles, yellow fever, rabies, and Japanese encephalitis formulations.¹³ It is manufactured from collagen extracted from bovine hide and bones, porcine hide and bones, and occasionally tuna skin. Bovine serum albumin (BSA) is the blood protein from cattle used widely in the cell cultures that produce vaccines. It appears in the excipient lists for the inactivated polio vaccine (IPOL), Pentacel, Vaxelis, Quadracel, and others.¹⁴ Both gelatin and BSA carry alpha-gal residues. They are mammalian proteins delivered by injection into muscle, alongside aluminum adjuvant.

Gelatin is used well beyond vaccines. It appears in heparin, pancreatic enzymes, thyroid supplements, intravenous fluids, suppositories, and magnesium stearate, among many other pharmaceutical products.¹⁵ The FDA does not require mammalian-source labeling, and manufacturers often cannot determine whether a given ingredient was sourced from mammalian tissue. Already-sensitized people encounter mammalian-derived material across a much wider set of exposures than food alone, which is part of why avoidance becomes so difficult to maintain once the sensitization is in place.

The Japanese medical literature contains the cleanest published case for the causal sequence. Between the late 1980s and the mid-1990s, the Japanese childhood schedule was restructured. The DTP whole-cell vaccine was replaced by an acellular version containing gelatin (DTaP). The age of administration was dropped from two years to three months. The new gelatin-containing DTaP was given before the live virus MMR, which also contained gelatin. Anaphylactic reactions to the MMR vaccine in Japanese children rose sharply, peaking in 1995 and 1996. Japanese investigators, in a series of peer-reviewed papers, concluded that the aluminum adjuvant in the DTaP had sensitized children to the trace gelatin proteins, and that subsequent exposure to gelatin in the MMR (or in food) triggered the anaphylactic response.¹⁶ Removal of gelatin from the DTaP was, in their words, “an ultimate solution for vaccine-related gelatin allergy.” New cases of gelatin allergy in Japanese children dropped after the formulation change.¹⁷

This is not a speculative reconstruction. It is the published, peer-reviewed conclusion of Japanese pediatric allergists working in the country’s own medical literature. They documented the schedule change, the rise in anaphylaxis, the mechanism, and the resolution after gelatin was removed. The Japanese literature is one of the rare admissions in mainstream science that vaccines cause food allergy through Richet’s mechanism, and the manufacturers did not contest it. The gelatin was removed from the Japanese DTaP, the cases dropped, and the matter was treated as resolved in Japan.

In the United States, gelatin was not removed from the affected vaccines. Children in the post-1989 cohort have continued to receive gelatin in MMR, MMRV, varicella, and other formulations across the expanded schedule, with bovine serum albumin in adjacent injections, and aluminum adjuvant in many of them. The schedule expansion that began in the late 1980s coincides almost exactly with the food allergy explosion that allergists describe as beginning around 1990.¹⁸ Vincent Pool and colleagues, in a 2002 Pediatrics paper, documented anti-gelatin antibodies in American children who had developed anaphylaxis after MMR vaccination.¹⁹ By 2012 and 2017, alpha-gal researchers themselves were making the vaccine connection in mainstream allergy journals. Mullins and colleagues in 2012 explored the relationship between red meat allergy, gelatin sensitization, and vaccines directly. Stone and colleagues in 2017 documented a patient developing anaphylaxis after a zoster vaccine containing porcine gelatin and bovine serum albumin, and identified fourteen VAERS reports of anaphylaxis following zoster vaccine, five with known beef, pork, gelatin, or alpha-gal allergy.²⁰ The connection was documented by the establishment’s own alpha-gal specialists. Nothing was changed.

When American children develop delayed anaphylaxis after eating red meat in the 2010s and 2020s, the cohort effect is unmistakable. They were born into a schedule containing mammalian proteins. They have received injections of mammalian proteins. Their laboratory tests show what the establishment calls anti-mammalian IgE. They react to mammalian proteins. The mechanism is the one Richet documented in 1902 and the one the Japanese confirmed in the 1990s. The tick is the cover.

Alpha-gal is one instance of a wider pattern. Peanut allergy, which exploded in the same post-1989 cohort, follows the same mechanism. Peanut-oil excipients in pediatric injections and oral preparations, sensitized through aluminum-adjuvanted injection, then triggered on subsequent food exposure. Heather Fraser documents this in detail in The Peanut Allergy Epidemic.²¹ The proteins differ. The mechanism does not.

---

The Aluminum Amplifier

A careful reader will ask at this point: gelatin appears in food. People eat marshmallows, fruit gums, and yogurt. Why doesn’t food exposure produce alpha-gal? The answer is the adjuvant.

Aluminum salts have been the dominant adjuvant in non-mRNA vaccines for the past century. A 1978 study observed that aluminum produces prolonged synthesis of what the establishment calls specific IgE against co-injected proteins.²² The mechanism is not subtle. The protein is the antigen. Aluminum is the amplifier. Aluminum creates a deposit at the injection site, holds the foreign protein in place, summons inflammatory cells, and amplifies the body’s response to the protein, producing what the literature describes as a sustained antibody response over weeks. Ingestion produces no such response because digestion does the work Richet described. Proteins are modified, broken down, and made tolerable. Injection bypasses digestion and pairs the foreign protein with an inflammatory amplifier. The result is sustained sensitization. Richet’s experiments used no aluminum and produced sensitization with sufficient protein dose alone. Aluminum lowers the threshold for sensitization at the lower protein doses present in vaccines.

This is why the gelatin in a marshmallow does not produce alpha-gal, and the gelatin in an MMR vaccine does. It is the same protein. The difference is how it gets in. Heather Fraser, surveying the literature in The Peanut Allergy Epidemic, summarizes the position. “It is hypothesized that the regular application of aluminium compound-containing vaccines on the entire population could be one of the factors leading to the observed increase of allergic diseases.”²³ The hypothesis was offered in 1978. The schedule was expanded anyway. The allergy epidemic followed.

---

What the Tick Story Cannot Explain

The Amish do not develop alpha-gal. They live in rural Pennsylvania, Ohio, Indiana, and elsewhere, surrounded by cattle and ticks. They are exposed to the lone star tick at rates the rest of the country could not match. They are also among the least-vaccinated populations in the United States. Researchers working with the Control Group Project, which followed more than 1,500 completely unvaccinated Americans across the age range out of a survey base of over 800,000, have noted that neither alpha-gal nor Lyme disease appears in the Amish or in the broader unvaccinated cohort at any meaningful rate.²⁴

This is the kind of natural experiment that mainstream epidemiology refuses to run. A population with maximum tick exposure, minimum vaccination exposure, and no detectable alpha-gal syndrome falsifies the tick hypothesis by itself. The standard allergist response, which is that the Amish must somehow be protected by their dairy diet or by some unspecified genetic factor or by reporting bias, is the same evasion that ran for decades around peanut allergy in non-Western populations. It is not a scientific reply. It is a holding pattern designed to avoid the structural conclusion the data is forcing.

The lone star tick has lived in the southeastern United States for centuries. Cattle have been there longer. Native Americans, early colonists, generations of farmers, and unvaccinated Amish communities have lived in proximity to both. No reliable population-level reports of meat allergy exist for any of them prior to the late twentieth century. The tick did not change. The schedule did. The cohort that develops alpha-gal is the cohort that has been injected with bovine proteins and aluminum adjuvant, a cohort that begins, with statistical clarity, around 1990.

A second falsification sits inside the establishment’s own laboratory work. No animal model of alpha-gal exists. No researcher has produced a carnivore that becomes allergic to meat after a tick bite. The molecular detection of alpha-gal in tick saliva, which the establishment cites as evidence of causation, is the same circular trick that virology uses to establish viruses. Find a molecule, assume a mechanism, declare the case closed. Detection is not causation. The amount of alpha-gal a tick could transfer in a single bite is orders of magnitude smaller than the amount delivered in a single vaccine dose, and the alpha-gal present in tick saliva most likely originates from the tick’s previous blood meal on a mammal in any case. The animal experiment that would settle the question has not been done, and is unlikely to be funded.

---

The Codes Arrived Around 2021

In the United States, no diagnosis is reimbursable without an ICD code. Doctors cannot bill, statisticians cannot count, and journals cannot publish epidemiological studies on conditions that have no entry in the coding manuals. The history of any disease label is partly the history of its administrative apparatus.

Lyme disease received its current ICD-10-CM code, A69.20 (Lyme disease, unspecified), when the United States transitioned from ICD-9 to ICD-10 in 2015. Lyme had been coded under earlier systems since the 1990s, but the ICD-10 transition consolidated the modern coding apparatus alongside CPT codes for ELISA, Western blot, and PCR-based testing.²⁵ This was the precedent. The disease label received a code, the testing codes followed, and the diagnostic infrastructure expanded. Cases multiplied because the coding made them billable.

As Sasha Latypova has documented in detail, alpha-gal syndrome had no dedicated ICD-10 code prior to the early 2020s. Physicians who suspected the condition used generic food allergy codes, which made population-level tracking impossible and limited the diagnosis to specialty practice. Around 2021, immediately following the mRNA rollout and the resulting wave of post-injection anaphylactic and hypersensitivity events that the establishment was unable to classify under existing categories, the United States introduced and began routinely using the following codes:

• Z91.014, Allergy to mammalian meats (the primary alpha-gal code)

• T78.1XXA, Adverse food reaction, anaphylaxis

• W57.XXXA, Tick bite or exposure

• Z87.892, Personal history of anaphylaxis²⁶

A doctor faced with a patient who developed unexplained anaphylaxis or extended symptoms after an mRNA injection now had a coding pathway that named ticks as the cause and never mentioned the needle. The clinician could bill. The patient received a label. The case entered population statistics under “alpha-gal syndrome, tick exposure” rather than under “adverse reaction following immunization,” for which there is, by design, no functional billing code in routine American practice.

The “explosion” of alpha-gal cases dates from this administrative event, not from any documented change in tick populations, tick behavior, or human exposure. Robert F. Kennedy Jr., as HHS Secretary, has publicly described alpha-gal as a “vector-borne illness” affecting half a million Americans.²⁷ The vector is not the tick. The vector is the code, the schedule, and the structural prohibition on diagnosing vaccine injury.

---

What It Was Always For

In 2017, S. Matthew Liao, director of the Center for Bioethics at New York University, walked onto a TED stage and proposed the following. “We could artificially induce mild intolerance to meat by stimulating our immune system against common bovine proteins, and in this way we can create an aversion to eating eco-unfriendly food. And we can do this for example by having meat patches kind of like nicotine patches. People can then wear these patches before they go out for dinner to curb their enthusiasm for eating meat.”²⁸

A year before the TED talk, Liao had already made the reference more explicit at the 2016 World Science Festival. “There’s this thing called the lone star tick where if it bites you you’ll become allergic to meat. I can sort of describe the mechanism. So that’s something that we can do through human engineering. We can kind of possibly address really big world problems through human engineering.”²⁹

The TED talk and the World Science Festival appearance are the public-facing summaries of an academic paper Liao co-authored years earlier with Anders Sandberg and Rebecca Roache of Oxford’s Future of Humanity Institute. The paper, titled “Human Engineering and Climate Change,” appeared in Ethics, Policy and Environment in 2012, and proposes precisely the deployment Liao described from the stage. Biomedical modification of the human population to induce meat aversion, among other interventions, as a policy response to climate change.³⁰ The chronology is worth noting. Liao published the academic argument in 2012, expanded the lone star tick framing publicly in 2016, and refined the meat-patches proposal for the TED stage in 2017. The proposal has been in the open for over a decade.

What follows from Liao’s record is straightforward. The mechanism is openly understood by the bioethics establishment. Liao could not propose deliberately sensitizing the population against bovine proteins as a climate intervention if the injection-induced sensitization mechanism were not understood to work. The same medical literature that publicly claims alpha-gal is mysterious and tick-borne contains, on the bioethics side, an explicit proposal to engineer it on purpose. The two stories cannot both be true. Either the mechanism is understood, in which case the tick narrative is a cover, or it is not understood, in which case Liao is proposing a policy with no biological basis. Liao is not proposing a policy with no biological basis. He is proposing one with a hundred and twenty years of foundational evidence behind it.

Liao framed his proposal as voluntary climate intervention. Meat patches that consumers would choose to wear. The mechanism is currently being deployed involuntarily through the schedule, on cohorts who never consented to sensitization and were not informed of the bovine protein content of their injections. The difference between voluntary and involuntary deployment is large. The underlying biology is identical.

The tick cover story does double duty. It absorbs the current wave of vaccine-induced cases by attributing them to a “vector-borne” cause, and it pre-normalizes the mechanism so that when deliberate “meat aversion” interventions are eventually deployed through patches, oral preparations, or modified vaccines, the public has already accepted that meat allergy is something that happens naturally. Liao’s TED talk explicitly draws on the tick as a precedent for what bioethics proposes to engineer. The narrative serves as both diagnostic shield and public-acceptance platform.

The question of intent is where the cui bono opens up. Pfizer’s Lyme vaccine pipeline represents a multi-billion-dollar revenue stream that depends on the public perception of tick-borne disease as a major and growing threat.³¹ Climate-policy infrastructure proposing population-level behavioral modification through induced allergy represents a structurally larger one. Both rest on the same documented mechanism. Both benefit from the same cover story.

---

The Documents Exist

Richet sensitized dogs to raw meat by injection in the early 1900s. The mechanism is in the 1913 Nobel lecture. Cetuximab patients in Tennessee developed the same response in the mid-2000s. The Chung paper is in the New England Journal of Medicine. Japanese pediatric allergists documented that gelatin in DTaP caused subsequent anaphylaxis to MMR and to food, and that removing the gelatin resolved the problem. The Nakayama and Sakaguchi papers are in the Journal of Allergy and Clinical Immunology. Aluminum adjuvant produces prolonged antibody synthesis against co-injected proteins. The Vasselev paper is in Allergy. The Amish are unvaccinated and have no alpha-gal. The Control Group Project tracks 1,500 unvaccinated Americans and finds none. The lone star tick has lived in the southeastern United States for centuries without producing population-level meat allergy in anyone except the cohort born into the post-1989 schedule. S. Matthew Liao stood on a TED stage in 2017 and proposed deploying the mechanism through meat patches. The video is online. The academic paper is in Ethics, Policy and Environment. The ICD code Z91.014 was added to the American coding manual in the early 2020s. It is in the official US documentation.

None of this is hidden. The papers are indexed in PubMed. The Nobel lectures are archived. The Chung paper is open access. The package inserts list gelatin and bovine serum albumin. The Japanese causal admission is in the peer-reviewed literature. The TED talk has been viewed tens of thousands of times. The ICD code is in the manual every American physician uses.

The story the establishment tells about ticks is one document. The story its own documents tell, about injection, about bovine proteins, about aluminum amplification, about the Japanese admission, about the unvaccinated absence, about the codes that arrived in the early 2020s, and about the bioethicist who has been proposing the deliberate version of this mechanism in print since 2012, is a different document. The second document is the longer one. It is also the one that does not need a tick to make its case.

Alpha-gal syndrome is anaphylaxis to mammalian proteins. It is caused by injection of those proteins. Aluminum adjuvant in the vaccine schedule amplifies and prolongs the response, but the injection of the proteins is the cause Richet documented. The condition was documented by a Nobel laureate before the cause of it was attributed to a tick. The cover story was constructed because the alternative is structurally inadmissible to the institutions that produce the science. The deliberate deployment of the same mechanism, openly proposed in academic journals and on TED stages as a population-level intervention, is already on the record.

Read the papers. Read the package inserts. Watch the TED talk. Look up the code.

---

How to Explain It to a 6-Year-Old

When you eat food, your tummy breaks it down into tiny pieces so your body can use it. That is your tummy’s job.

If someone uses a needle to put bits of meat straight into your blood, your body never gets to break them down. Your body says, “Wait, that doesn’t belong here.” It remembers the meat as something bad.

Later, when you eat that meat for dinner, your body sees it and gets scared. It thinks the meat is back to hurt you. It makes you sick. Sometimes very sick.

A long time ago, a scientist named Richet did this on purpose with dogs. He gave them shots with meat in them, then he fed them meat. The dogs got very sick. He won a big prize for figuring this out.

Today, when children get shots, sometimes those shots have tiny bits of cow in them. The cow bits are part of how the shot is made. But the body still remembers. Years later, when those children grow up and eat a hamburger, some of them get very sick.

The doctors do not say, “It was the shot.” They say, “It was a tick.” A tick is a tiny bug that lives in the woods.

But the children who never got shots, and who live near lots of ticks, do not get sick from hamburgers. The children who got shots, and who have never seen a tick, do get sick from hamburgers.

So we know who did it. It was not the tick.

---

References

1. C. Richet, “Anaphylaxis,” Nobel Lecture, December 11, 1913, Nobel Lectures, Physiology or Medicine 1901–1921 (Amsterdam: Elsevier, 1967).

2. H. Fraser, The Peanut Allergy Epidemic: What’s Causing It and How to Stop It (New York: Skyhorse, 2011), 45–48.

3. Richet, Nobel Lecture, 1913.

4. Ibid.

5. C. Richet, “Address to the International Medical Congress, London, 1913,” cited in Fraser, The Peanut Allergy Epidemic, 46.

6. C.H. Chung, B. Mirakhur, E. Chan, Q.T. Le, J. Berlin, M. Morse, B.A. Murphy, S.M. Satinover, J. Hosen, D. Mauro, R.J. Slebos, Q. Zhou, D. Gold, T. Hatley, D.J. Hicklin, T.A.E. Platts-Mills, “Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-Alpha-1,3-Galactose,” New England Journal of Medicine 358, no. 11 (2008): 1109–1117.

7. Ibid., reporting regional rates of 22% in Tennessee and North Carolina versus less than 1% in northeastern US centers.

8. Ibid.

9. S.P. Commins, S.M. Satinover, J. Hosen, J. Mozena, L. Borish, B.D. Lewis, J.A. Woodfolk, T.A.E. Platts-Mills, “Delayed Anaphylaxis, Angioedema, or Urticaria After Consumption of Red Meat in Patients with IgE Antibodies Specific for Galactose-Alpha-1,3-Galactose,” Journal of Allergy and Clinical Immunology 123, no. 2 (2009): 426–433.

10. R.A. Wood, C.A. Camargo Jr., P. Lieberman, H.A. Sampson, L.B. Schwartz, M. Zitt, C. Collins, M. Tringale, M. Wilkinson, J. Boyle, F.E.R. Simons, “Anaphylaxis in America: The Prevalence and Characteristics of Anaphylaxis in the United States,” Journal of Allergy and Clinical Immunology 133, no. 2 (February 2014): 461–467, doi:10.1016/j.jaci.2013.08.016. Data collected in 2013.

11. K. Shaker, S. Greenberger, “Idiopathic Anaphylaxis,” Journal of Allergy and Clinical Immunology: In Practice 2, no. 3 (2014): 243–250, noting that idiopathic anaphylaxis accounts for approximately 30% to 60% of adult cases. See also M. Teller, “Alpha-Gal Syndrome and Ticks: A False Trail?” Wise Traditions in Food, Farming and the Healing Arts, Weston A. Price Foundation, Spring 2020 (published April 27, 2020), citing the 39% idiopathic figure from the Wood et al. survey data.

12. Teller, “Alpha-Gal Syndrome and Ticks: A False Trail?” Spring 2020.

13. Centers for Disease Control and Prevention, “Vaccine Excipient Summary,” current edition; K. Nelson, “Chickenpox and Shingles Vaccines,” Wise Traditions (Spring 2020).

14. E. Geehr, Unavoidably Unsafe, vaccine excipient listings for IPOL, Pentacel, Pediarix, Kinrix, Vaxelis, Quadracel.

15. Teller, “Alpha-Gal Syndrome and Ticks: A False Trail?” Spring 2020, on gelatin in heparin, pancreatic enzymes, thyroid supplements, intravenous fluids, suppositories, magnesium stearate, and other pharmaceutical products; on FDA labeling requirements for mammalian-source ingredients.

16. T. Nakayama, C. Aizawa, H. Kuno-Sakai, “A Clinical Analysis of Gelatin Allergy and Determination of Its Causal Relationship to the Previous Administration of Gelatin-Containing Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids,” Journal of Allergy and Clinical Immunology 103, no. 2 (1999): 321–325; M. Sakaguchi et al., “Food Allergy to Gelatin in Children with Systemic Immediate-Type Reactions, Including Anaphylaxis, to Vaccine,” Journal of Allergy and Clinical Immunology 98, no. 1 (1996): 1058–1061; J.M. Kelso, M.B. Jones, J.W. Yunginger, “Anaphylaxis to Measles, Mumps, and Rubella Vaccine Mediated by IgE to Gelatin,” Journal of Allergy and Clinical Immunology 91, no. 4 (1993): 867–872.

17. T. Nakayama, C. Aizawa, “Change in Gelatin Content of Vaccines Associated with Reduction in Reports of Allergic Reactions,” Journal of Allergy and Clinical Immunology 106, no. 3 (2000): 591–592.

18. Fraser, The Peanut Allergy Epidemic, 1–25, on the timing of the food allergy explosion relative to schedule expansion.

19. V. Pool, M.M. Braun, J.M. Kelso, et al., “Prevalence of Anti-Gelatin IgE Antibodies in People with Anaphylaxis After Measles-Mumps-Rubella Vaccine in the United States,” Pediatrics 110, no. 6 (December 2002): e71.

20. R.J. Mullins, H. James, T.A.E. Platts-Mills, S.P. Commins, “The Relationship Between Red Meat Allergy and Sensitization to Gelatin and Galactose-Alpha-1,3-Galactose,” Journal of Allergy and Clinical Immunology 129, no. 5 (2012): 1334–1342.e1; C.A. Stone Jr., J.A. Hemler, S.P. Commins, et al., “Anaphylaxis After Zoster Vaccine: Implicating Alpha-Gal Allergy as a Possible Mechanism,” Journal of Allergy and Clinical Immunology 139, no. 5 (2017): 1710–1713.e2. Surfaced in Teller, “Alpha-Gal Syndrome and Ticks: A False Trail?” Spring 2020.

21. Fraser, The Peanut Allergy Epidemic, on peanut oil excipients, aluminum-adjuvanted sensitization, and the post-1989 cohort effect.

22. T.L. Vasselev, “Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid,” Allergy 33, no. 3 (June 1978): 155–159.

23. Fraser, The Peanut Allergy Epidemic, citing Vasselev (1978) and Workshop on Aluminum in Vaccines, US Department of Health and Human Services, 2000.

24. The Control Group Project, www.controlgroup.org; D. Roytas, Can You Catch a Cold? (2024); S. Latypova, “Weaponized Ticks: A Mini Review,” Due Diligence and Art, May 25, 2026.

25. Centers for Disease Control and Prevention and the American Medical Association, ICD-10-CM transition documentation, October 2015; A69.20 (Lyme disease, unspecified) as the consolidated code under ICD-10-CM.

26. ICD-10-CM coding manual entries Z91.014 (Allergy to mammalian meats), T78.1XXA (Adverse food reaction, anaphylaxis), W57.XXXA (Tick bite), Z87.892 (Personal history of anaphylaxis); S. Latypova, “Weaponized Ticks,” Due Diligence and Art, May 25, 2026.

27. R.F. Kennedy Jr., public remarks as HHS Secretary, May 2026, cited in Latypova, “Weaponized Ticks.”

28. S.M. Liao, “Tackling Climate Change Through Human Engineering?” TED Talks Archive, recorded 2017, published November 21, 2017.

29. S.M. Liao, “We can make you allergic to meat,” World Science Festival panel, 2016.

30. S.M. Liao, A. Sandberg, R. Roache, “Human Engineering and Climate Change,” Ethics, Policy and Environment 15, no. 2 (2012): 206–221, doi:10.1080/21550085.2012.685574.

31. Pfizer Inc., investor briefings on the Lyme vaccine pipeline; Latypova, “Weaponized Ticks,” for cui bono analysis.